Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone reduces key molecules needed for early pregnancy in rats.

Finasteride effectively treats hair loss in transgender men with few side effects.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

FUE hair transplantation using a micromotor is effective and gives natural results with few complications.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

Different drugs are used to manage breeding, prevent or end pregnancy, and treat reproductive issues in dogs and cats.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Early hair loss may indicate prostate issues.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Inositol shows promise in treating PCOS and other health issues, but more research is needed.